-
Abstract Number: PO0037
Factor Infusion in Haemophilia in The Morning Increases Profilaxy Efficiency
-
Abstract Number: VPB1418
Factor V Leiden polymorphism, prothrombin G20210A mutation, and methylenetetrahydrofolate reductase C677T polymorphism in recurrent pregnancy loss.
-
Abstract Number: VPB0207
Factor VIII K1813A has high affinity for activated factor IX and enhances global coagulation function
-
Abstract Number: OC 28.1
Factor X – Protease activated receptor-2 signaling in the regulation of diet-induced obesity
-
Abstract Number: OC 74.5
Factor XI and Plasma Kallikrein apple domain structures reveal alternate kininogen bound complexes
-
Abstract Number: PB0595
Factor XII activation by NET accumulation aggravates COVID-19-associated pulmonary thrombo-inflammation
-
Abstract Number: OC 03.1
Factor XII heavy chain structure
-
Abstract Number: OC 24.4
Factor XIII levels correlate with fibrinogen concentrations in patients with venous malformations and chronic disseminated intravascular coagulopathy
-
Abstract Number: PB0446
Factors Associated with Anticoagulant Treatment Initiation Among Venous Thromboembolism Patients with Cancer
-
Abstract Number: VPB0467
Factors influencing the decision making on thrombolytic therapy in normotensive patients with pulmonary embolism: data from SIRENA registry
-
Abstract Number: OC 65.5
Factors influencing anti-Xa assays in different groups of critically ill and non-critically ill patients receiving unfractionated heparin: a multicenter prospective study
-
Abstract Number: PB1200
Factors Influencing Health-related Quality of Life in Patients with Immune Thrombocytopenia
-
Abstract Number: OC 04.2
Factors influencing time from initial presentation to start of plasma exchange in patients with acute thrombotic thrombocytopenic purpura in the United Kingdom
-
Abstract Number: PB0416
Falsely elevated PT-INR results measured with Quick point-of-care methods and Quick laboratory method in patients with antiphospholipid syndrome.
-
Abstract Number: PB0398
Fatty acids negatively regulate platelet function through formation of noncanonical 15-lipoxygenase-derived eicosanoids
-
Abstract Number: PB0465
Feasibility Study of Patient Self-Management of Warfarin using the Fearon Algorithm
-
Abstract Number: PB1405
Features of changes in platelet aggregation activity in pregnant women with preeclampsia
-
Abstract Number: OC 46.1
Fibrin Film Formation is Enhanced by Red Blood Cells and Reduces Platelet Spreading
-
Abstract Number: PB0321
Fibrin monomers: a new useful tool to monitor argatroban in patients with Heparin-Induced Thrombocytopenia – A single-center retrospective study
-
Abstract Number: PB0732
Fibrin Promotes Glioblastoma Progression via Focal Adhesion Kinase
-
Abstract Number: OC 29.3
Fibrinogen αC-Connector is Critical for Fibrin Fiber Assembly and Mechanical Strength
-
Abstract Number: VPB0996
FiiRST-2; a prospective, randomized study of clotting factor concentrates versus standard massive hemorrhage protocol in severely bleeding trauma patients
-
Abstract Number: PB0423
Finding the Gap in Pediatric Post-Thrombotic Syndrome
-
Abstract Number: VPB1297
Fingerprint of novel circulating microRNAs identify patients with stroke-embolic stroke of undetermined source
-
Abstract Number: VPB0693
First year report of the multicenter prospective cohort study on ischemic events in adult patients with hemophilia (ADVANCE Japan)
-
Abstract Number: PB1152
Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin: Analysis of Antithrombin Levels and Thrombin Generation from a Phase 3 Study in People with Hemophilia A or B With Inhibitors
-
Abstract Number: OC 50.2
Fitusiran, an Investigational siRNA Therapeutic Targeting Antithrombin: Analysis of Antithrombin Levels and Thrombin Generation from a Phase 3 Study in People with Hemophilia A or B Without inhibitors
-
Abstract Number: PB0166
Five cases of Acquired Haemophilia A (AHA) following COVID-19 vaccination in Australia
-
Abstract Number: PB0187
FIX binding to collagen IV generates thrombin via the extrinsic tenase
-
Abstract Number: VPB0904
Flow cytometry test with ADP stimulation for platelet functional activity assessment
-
Abstract Number: PB1321
Focused on cerebral venous thrombosis
-
Abstract Number: OC 37.2
Follicular regulatory T cells promote anti-FVIII inhibitor development in hemophilia A mice
-
Abstract Number: PB1203
Fostamatinib for the Treatment of Immune Thrombocytopenia in a Real-World Setting: A Case Series of Five Patients
-
Abstract Number: OC 45.2
Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb/IIIa dependent platelet activation
-
Abstract Number: VPB0962
Fracture mechanics of human blood clots: fibrinogen concentration is a critical determinant of clot toughness
-
Abstract Number: PB0953
Free protein S antigen represents more reliable assay for protein S deficiency testing compared with protein S activity and should be used as the first and main test in the diagnostic protocol
-
Abstract Number: PB0880
Freeze Dried Platelet Derivatives (Thrombosomes®) Retain Hemostatic Properties During Heparin Complexation with Protamine
-
Abstract Number: PB0541
Freeze-dried plasma development and assessment of biochemical quality
-
Abstract Number: VPB1167
Frequency and Quantification of Inhibitors in Congenital Coagulation Disorder Patients – An Experience at Tertiary Care Paediatric Hospital.
-
Abstract Number: VPB1346
Frequency and risk factors associated with thromboembolic events in a Sickle Cell Disease cohort
-
Abstract Number: PB0733
Frequency of Factor II, Factor V Leiden and MTHFR mutations in children with cancer
-
Abstract Number: PB1229
Frequency of reported thrombotic adverse events and clinical outcomes associated with three COVID-19 vaccines
-
Abstract Number: PB0832
Frequency of VWF single nucleotide variants in a single institution of Argentina.
-
Abstract Number: PB0500
Frequency, reasons and duration of hospitalization in patients with end-stage kidney disease on hemodialysis: Prospective results of VIVALDI
-
Abstract Number: OC 40.1
FRONTIER1: A Phase 1/2 Dose Escalation Study of a Novel Factor VIIIa Mimetic Bispecific Antibody, Mim8, for Evaluation of Safety, Pharmacokinetics, and Efficacy
-
Abstract Number: PB0872
Fully automated platelet Differential Interference Contrast image analysis via deep learning.
-
Abstract Number: PB1254
Functional Alterations Involved In Increased Bleeding In Hereditary Hemorrhagic Telangiectasia Mouse Models
-
Abstract Number: PB0742
Functional changes in platelets and coagulation during asexual and sexual parasitemia in a controlled human malaria infection
-
Abstract Number: OC 11.2
Functional characterisation of coagulopathy in isolated traumatic brain injury
-
Abstract Number: OC 76.1
Functional characterization and structural modeling of DNA-aptamers targeting activated coagulation Factor XIII
-
Abstract Number: PB0379
Functional expression of GFP-tagged integrin αIIb in a transgenic (knockin) mouse line
-
Abstract Number: OC 33.1
Functional studies on the interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia
-
Abstract Number: PB0871
Fusogenic liposomes label human platelets without impacting normal platelet function
-
Abstract Number: OC 62.4
FVIII and D-dimer values at trough and peak concentrations of direct oral anticoagulants: important considerations for using these tests in assissting clinical decision for risk stratification scheme
-
Abstract Number: PB0197
FVIII stimulation causes a variable response in FVIII-specific third generation chimeric antigen receptor (CAR)-transduced T cells.
-
Abstract Number: OC 47.1
FVIII-reactive CD4 T cells isolated from non-hemophilic blood respond to multiple epitopes in the FVIII protein
-
Abstract Number: PB0184
FVIII-specific Immune Response in Hemophilia A Mice Upon Infection
-
Abstract Number: PB0487
FXIII CONCENTRATE USE IN UNCONTRALABLE BLEEDING AFTER CARDIAC SURGERY– WHAT IS THE ROLE? – A CASE REPORT
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.